Chitosan oligosaccharide: Biological activities and potential therapeutic applications

Pharmacology and Therapeutics

Volumn 170, Issue , 2017, Pages 80-97

  Muanprasat, Chatchai ^a   Chatsudthipong, Varanuj ^a  

^a Mahidol University ^*  (Thailand)

Author keywords

Chitin; Chitosan; Chitosan oligosaccharide; Drug discovery; Polymers

Indexed keywords

ANTILIPEMIC AGENT; ANTIOBESITY AGENT; CHITOSAN; CHITOSAN OLIGOSACCHARIDE; NEUROPROTECTIVE AGENT; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CALCIUM ABSORPTION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; ENHANCER REGION; GENE TARGETING; HUMAN; IMMUNOMODULATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REGENERATION; REVIEW; ANIMAL; CHEMISTRY; DRUG DESIGN; METABOLISM; SOLUBILITY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CHITOSAN; DRUG DESIGN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OLIGOSACCHARIDES; SOLUBILITY;

EID: 85006137671     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.10.013     Document Type: Review

References (205)

1. Aam, B.B., Heggset, E.B., Norberg, A.L., Sorlie, M., Varum, K.M., Eijsink, V.G., Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 8 (2010), 1482–1517.
2. Aied, A., Greiser, U., Pandit, A., Wang, W., Polymer gene delivery: overcoming the obstacles. Drug Discov Today 18 (2013), 1090–1098.
3. Areco, V., Rivoira, M.A., Rodriguez, V., Marchionatti, A.M., Carpentieri, A., Tolosa de Talamoni, N., Dietary and pharmacological compounds altering intestinal calcium absorption in humans and animals. Nutr Res Rev 28 (2015), 83–99.
4. Artan, M., Karadeniz, F., Karagozlu, M.Z., Kim, M.M., Kim, S.K., Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr Res 345 (2010), 656–662.
5. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
6. Atkinson, A.B., Robertson, J.I.S., Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 314 (1979), 836–839.
7. Bahar, B., O'Doherty, J.V., Maher, S., McMorrow, J., Sweeney, T., Chitooligosaccharide elicits acute inflammatory cytokine response through AP-1 pathway in human intestinal epithelial-like (Caco-2) cells. Mol Immunol 51 (2012), 283–291.
8. Bahar, B., O'Doherty, J.V., O'Doherty, A.M., Sweeney, T., Chito-oligosaccharide inhibits the de-methylation of a ‘CpG’ island within the leptin (LEP) promoter during adipogenesis of 3T3-L1 cells. PLoS One, 8, 2013, e60011.
9. Barroso Aranda, J., Contreras, F., Bagchi, D., Preuss, H.G., Efficacy of a novel chitosan formulation on fecal fat excretion: a double-blind, crossover, placebo-controlled study. J Med 33 (2002), 209–225.
10. Bronner, F., Pansu, D., Nutritional aspects of calcium absorption. J Nutr 129 (1999), 9–12.
11. Byun, H.-G., Kim, Y.-T., Park, P.-J., Lin, X., Kim, S.-K., Chitooligosaccharides as a novel β-secretase inhibitor. Carbohydr Polym 61 (2005), 198–202.
12. Cader, M.Z., Kaser, A., Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62 (2013), 1653–1664.
13. Cai, Z., Hussain, M.D., Yan, L.J., Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Int J Neurosci 124 (2014), 307–321.
14. Cerda, C., Sanchez, C., Climent, B., Vazquez, A., Iradi, A., El Amrani, F., et al. Oxidative stress and DNA damage in obesity-related tumorigenesis. Adv Exp Med Biol 824 (2014), 5–17.
15. Chae, S.Y., Jang, M.K., Nah, J.W., Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release 102 (2005), 383–394.
16. Charan, S., Sanjiv, K., Singh, N., Chien, F.C., Chen, Y.F., Nergui, N.N., et al. Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation. Bioconjug Chem 23 (2012), 2173–2182.
17. Cho, E.J., Rahman, M.A., Kim, S.W., Baek, Y.M., Hwang, H.J., Oh, J.Y., et al. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J Microbiol Biotechnol 18 (2008), 80–87.
18. Choi, E.H., Yang, H.P., Chun, H.S., Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation. Nutr Res 32 (2012), 218–228.
19. Chung, M.J., Park, J.K., Park, Y.I., Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and asthma model mice. Int Immunopharmacol 12 (2012), 453–459.
20. Cnubben, N.H., Tel, S.L., Hemmes, M.A., Langenkamp-Brand, A., Grossouw, D., Jansen, H.T., et al. A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-oleic acid in adult female Gottingen minipigs. BMC Obes, 3, 2016, 18.
21. Craig, L.A., Hong, N.S., McDonald, R.J., Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev 35 (2011), 1397–1409.
22. Dell'Italia, L.J., Husain, A., Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr Opin Cardiol 17 (2002), 374–379.
23. Diaz de Barboza, G., Guizzardi, S., Tolosa de Talamoni, N., Molecular aspects of intestinal calcium absorption. World J Gastroenterol 21 (2015), 7142–7154.
24. Dong, W., Han, B., Feng, Y., Song, F., Chang, J., Jiang, H., et al. Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation. Biomacromolecules 11 (2010), 1527–1533.
25. Dong, W., Han, B., Shao, K., Yang, Z., Peng, Y., Yang, Y., et al. Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats. J Mater Sci Mater Med 23 (2012), 2945–2952.
26. Dou, J., Tan, C., Du, Y., Bai, X., Wang, K., Ma, X., Effects of chitooligosaccharides on rabbit neutrophils in vitro. Carbohydr Polym 69 (2007), 209–213.
27. Du, Y.Z., Lu, P., Yuan, H., Zhou, J.P., Hu, F.Q., Quaternary complexes composed of plasmid DNA/protamine/fish sperm DNA/stearic acid grafted chitosan oligosaccharide micelles for gene delivery. Int J Biol Macromol 48 (2011), 153–159.
28. Du, Y.Z., Lu, P., Zhou, J.P., Yuan, H., Hu, F.Q., Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation. Int J Pharm 391 (2010), 260–266.
29. Du, Y.Z., Wang, L., Yuan, H., Hu, F.Q., Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells. Int J Biol Macromol 48 (2011), 215–222.
30. Du, Y.Z., Wang, L., Yuan, H., Wei, X.H., Hu, F.Q., Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. Colloids Surf B Biointerfaces 69 (2009), 257–263.
31. Du, Y.Z., Ying, X.Y., Wang, L., Zhai, Y., Yuan, H., Yu, R.S., et al. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles. Int J Pharm 392 (2010), 164–169.
32. Dyawanapelly, S., Koli, U., Dharamdasani, V., Jain, R., Dandekar, P., Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Drug Deliv Transl Res 6 (2016), 365–379.
33. Dzoyem, J.P., Tsamo, A.T., Melong, R., Mkounga, P., Nkengfack, A.E., McGaw, L.J., et al. Cytotoxicity, nitric oxide and acetylcholinesterase inhibitory activity of three limonoids isolated from Trichilia welwitschii (Meliaceae). Biol Res, 48, 2015, 57.
34. Ebihara, K., Schneeman, B.O., Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J Nutr 119 (1989), 1100–1106.
35. Egan, A.M., O'Doherty, J.V., Vigors, S., Sweeney, T., Prawn shell chitosan exhibits anti-obesogenic potential through alterations to appetite, affecting feeding behaviour and satiety signals in vivo. PLoS One, 11, 2016, e0149820.
36. Egan, A.M., Sweeney, T., Hayes, M., O'Doherty, J.V., Prawn shell chitosan has anti-obesogenic properties, influencing both nutrient digestibility and microbial populations in a pig model. PLoS One, 10, 2015, e0144127.
37. Einbu, A., Grasdalen, H., Vårum, K.M., Kinetics of hydrolysis of chitin/chitosan oligomers in concentrated hydrochloric acid. Carbohydr Res 342 (2007), 1055–1062.
38. El-Sayed, N.S., Shirazi, A.N., El-Meligy, M.G., El-Ziaty, A.K., Nagieb, Z.A., Parang, K., et al. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter. Int J Biol Macromol 87 (2016), 611–622.
39. Emami, J., Rezazadeh, M., Rostami, M., Hassanzadeh, F., Sadeghi, H., Mostafavi, A., et al. Co-delivery of paclitaxel and alpha-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm 41 (2015), 1137–1147.
40. Eom, T.K., Ryu, B., Lee, J.K., Byun, H.G., Park, S.J., Kim, S.K., Beta-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides. J Enzyme Inhib Med Chem 28 (2013), 214–217.
41. Fang, I.M., Yang, C.H., Yang, C.M., Chitosan oligosaccharides attenuate ocular inflammation in rats with experimental autoimmune anterior uveitis. Mediat Inflamm, 2014, 2014, 827847.
42. Feng, J., Zhao, L., Yu, Q., Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem Biophys Res Commun 317 (2004), 414–420.
43. Fernandes, J.C., Borges, M., Nascimento, H., Bronze-da-Rocha, E., Ramos, O.S., Pintado, M.E., et al. Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes. Int J Biol Macromol 49 (2011), 433–438.
44. Fernandes, J.C., Eaton, P., Nascimento, H., Gião, M.S., Ramos, Ó.S., Belo, L., et al. Antioxidant activity of chitooligosaccharides upon two biological systems: erythrocytes and bacteriophages. Carbohydr Polym 79 (2010), 1101–1106.
45. Fernandes, J.C., Spindola, H., de Sousa, V., Santos-Silva, A., Pintado, M.E., Malcata, F.X., Anti-inflammatory activity of chitooligosaccharides in vivo. Mar Drugs 8 (2010), 1763–1768.
46. Fernandes, J.C., Sereno, J., Garrido, P., Parada, B., Cunha, M.F., Reis, F., et al. Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model. Mar Drugs 10 (2012), 2661–2675.
47. Fernandes, J.C., Tavaria, F.K., Soares, J.C., Ramos, O.S., Joao Monteiro, M., Pintado, M.E., et al. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems. Food Microbiol 25 (2008), 922–928.
48. Gades, M.D., Stern, J.S., Chitosan supplementation does not affect fat absorption in healthy males fed a high-fat diet, a pilot study. Int J Obes Relat Metab Disord 26 (2002), 119–122.
49. Gades, M.D., Stern, J.S., Chitosan supplementation and fecal fat excretion in men. Obes Res 11 (2003), 683–688.
50. Ghaisas, S., Maher, J., Kanthasamy, A., Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158 (2016), 52–62.
51. Gorzelanny, C., Poppelmann, B., Strozyk, E., Moerschbacher, B.M., Schneider, S.W., Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells. Biomacromolecules 8 (2007), 3035–3040.
52. Gotoh, T., Matsushima, K., Kikuchi, K., Preparation of alginate-chitosan hybrid gel beads and adsorption of divalent metal ions. Chemosphere 55 (2004), 135–140.
53. Guerciolini, R., Radu-Radulescu, L., Boldrin, M., Dallas, J., Moore, R., Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes Res 9 (2001), 364–367.
54. Guerry, A., Cottaz, S., Fleury, E., Bernard, J., Halila, S., Redox-stimuli responsive micelles from DOX-encapsulating polycaprolactone-g-chitosan oligosaccharide. Carbohydr Polym 112 (2014), 746–752.
55. Guminska, M., Ignacak, J., Wojcik, E., In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT). Pol J Pharmacol 48 (1996), 495–501.
56. Gunther, C., Neumann, H., Neurath, M.F., Becker, C., Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 62 (2013), 1062–1071.
57. Hamer, S.N., Cord-Landwehr, S., Biarnes, X., Planas, A., Waegeman, H., Moerschbacher, B.M., et al. Enzymatic production of defined chitosan oligomers with a specific pattern of acetylation using a combination of chitin oligosaccharide deacetylases. Sci Rep, 5, 2015, 8716.
58. Han, Y., Zhao, L., Yu, Z., Feng, J., Yu, Q., Role of mannose receptor in oligochitosan-mediated stimulation of macrophage function. Int Immunopharmacol 5 (2005), 1533–1542.
59. Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996), 353–364.
60. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
61. Hasegawa, M., Yagi, K., Iwakawa, S., Hirai, M., Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res 92 (2001), 459–466.
62. Hayashi, K., Ito, M., Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol Pharm Bull 25 (2002), 188–192.
63. Hong, S.P., Kim, M.H., Oh, S.W., Han, C.K., Kim, Y.H., ACE inhibitory and antihypertensive effect of chitosan oligosaccharides in SHR. Korean J Food Sci Technol 30 (1998), 1476–1479.
64. Hsieh, Y.-L., Yao, H.-T., Cheng, R.-S., Chiang, M.-T., Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats. J Med Food 15 (2012), 453–460.
65. Hu, F.Q., Jiang, X.H., Huang, X., Wu, X.L., Yuan, H., Wei, X.H., et al. Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles. J Drug Target 17 (2009), 384–391.
66. Hu, F.Q., Liu, L.N., Du, Y.Z., Yuan, H., Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials 30 (2009), 6955–6963.
67. Hu, F.Q., Wu, X.L., Du, Y.Z., You, J., Yuan, H., Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur J Pharm Biopharm 69 (2008), 117–125.
68. Hu, F.Q., Zhao, M.D., Yuan, H., You, J., Du, Y.Z., Zeng, S., A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm 315 (2006), 158–166.
69. Huang, L., Chen, J., Cao, P., Pan, H., Ding, C., Xiao, T., et al. Anti-obese effect of glucosamine and chitosan oligosaccharide in high-fat diet-induced obese rats. Mar Drugs 13 (2015), 2732–2756.
70. Huang, H.C., Hong, L., Chang, P., Zhang, J., Lu, S.Y., Zheng, B.W., et al. Chitooligosaccharides attenuate Cu2 +-induced cellular oxidative damage and cell apoptosis involving Nrf2 activation. Neurotox Res 27 (2015), 411–420.
71. Huang, R., Mendis, E., Kim, S.-K., Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification. Bioorg Med Chem 13 (2005), 3649–3655.
72. Huang, R., Mendis, E., Rajapakse, N., Kim, S.K., Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci 78 (2006), 2399–2408.
73. Huang, B., Xiao, D., Tan, B., Xiao, H., Wang, J., Yin, J., et al. Chitosan oligosaccharide reduces intestinal inflammation that involves calcium-sensing receptor (CaSR) activation in lipopolysaccharide (LPS)-challenged piglets. J Agric Food Chem 64 (2016), 245–252.
74. Iroyukifujita, H., Eiichiyokoyama, K., Yoshikawa, M., Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65 (2000), 564–569.
75. Je, J.Y., Kim, S.K., Water-soluble chitosan derivatives as a BACE1 inhibitor. Bioorg Med Chem 13 (2005), 6551–6555.
76. Je, J.Y., Kim, S.K., Chitooligosaccharides as potential nutraceuticals: production and bioactivities. Adv Food Nutr Res 65 (2012), 321–336.
77. Je, J.-Y., Park, P.-J., Kim, S.-K., Free radical scavenging properties of hetero-chitooligosaccharides using an ESR spectroscopy. Food Chem Toxicol 42 (2004), 381–387.
78. Je, J.-Y., Park, P.-J., Kim, B., Kim, S.-K., Antihypertensive activity of chitin derivatives. Biopolymers 83 (2006), 250–254.
79. Jo, S.-H., Ha, K.-S., Lee, J.-W., Kim, Y.-C., Apostolidis, E., Kwon, Y.-I., The reduction effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose levels in healthy individuals. Food Sci Biotechnol 23 (2014), 971–973.
80. Joodi, G., Ansari, N., Khodagholi, F., Chitooligosaccharide-mediated neuroprotection is associated with modulation of Hsps expression and reduction of MAPK phosphorylation. Int J Biol Macromol 48 (2011), 726–735.
81. Ju, C., Yue, W., Yang, Z., Zhang, Q., Yang, X., Liu, Z., et al. Antidiabetic effect and mechanism of chitooligosaccharides. Biol Pharm Bull 33 (2010), 1511–1516.
82. Jung, W.K., Moon, S.H., Kim, S.K., Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats. Life Sci 78 (2006), 970–976.
83. Kang, N.H., Lee, W.K., Yi, B.R., Park, M.A., Lee, H.R., Park, S.K., et al. Modulation of lipid metabolism by mixtures of protamine and chitooligosaccharide through pancreatic lipase inhibitory activity in a rat model. Lab Anim Res 28 (2012), 31–38.
84. Kao, C.H., Hsiang, C.Y., Ho, T.Y., Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis. PLoS One, 7, 2012, e34969.
85. Karadeniz, F., Artan, M., Kong, C.-S., Kim, S.-K., Chitooligosaccharides protect pancreatic β-cells from hydrogen peroxide-induced deterioration. Carbohydr Polym 82 (2010), 143–147.
86. Karin, M., Clevers, H., Reparative inflammation takes charge of tissue regeneration. Nature 529 (2016), 307–315.
87. Kean, T., Thanou, M., Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62 (2010), 3–11.
88. Khodagholi, F., Eftekharzadeh, B., Maghsoudi, N., Rezaei, P.F., Chitosan prevents oxidative stress-induced amyloid beta formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF-kappaB. Mol Cell Biochem 337 (2010), 39–51.
89. Kim, S.-K., Rajapakse, N., Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review. Carbohydr Polym 62 (2005), 357–368.
90. Kim, E., Young, S.G., Genetically modified mice for the study of apolipoprotein B. J Lipid Res 39 (1998), 703–723.
91. Kim, J.-G., Jo, S.-H., Ha, K.-S., Kim, S.-C., Kim, Y.-C., Apostolidis, E., et al. Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action. BMC Complement Altern Med, 14, 2014, 272.
92. Kim, J.H., Kim, Y.S., Hwang, J.W., Han, Y.K., Lee, J.S., Kim, S.K., et al. Sulfated chitosan oligosaccharides suppress LPS-induced NO production via JNK and NF-kappaB inactivation. Molecules 19 (2014), 18232–18247.
93. Kim, H.J., Ahn, H.Y., Kwak, J.H., Shin, D.Y., Kwon, Y.-I., Oh, C.-G., et al. The effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetes. Food Funct 5 (2014), 2662–2669.
94. Kim, J.N., Chang, I.Y., Kim, H.I., Yoon, S.P., Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic rats. Islets 1 (2009), 111–116.
95. Kim, H.M., Hong, S.H., Yoo, S.J., Baek, K.S., Jeon, Y.J., Choung, S.Y., Differential effects of chitooligosaccharides on serum cytokine levels in aged subjects. J Med Food 9 (2006), 427–430.
96. Kim, S.K., Park, P.J., Yang, H.P., Han, S.S., Subacute toxicity of chitosan oligosaccharide in Sprague–Dawley rats. Arzneimittelforschung 51 (2001), 769–774.
97. Kim, M.S., Sung, M.J., Seo, S.B., Yoo, S.J., Lim, W.K., Kim, H.M., Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid beta peptide and interleukin-1beta. Neurosci Lett 321 (2002), 105–109.
98. Kittur, F.S., Vishu Kumar, A.B., Varadaraj, M.C., Tharanathan, R.N., Chitooligosaccharides—preparation with the aid of pectinase isozyme from Aspergillus niger and their antibacterial activity. Carbohydr Res 340 (2005), 1239–1245.
99. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999), 656–660.
100. Koleva, D.I., Orbetzova, M.M., Atanassova, P.K., Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Med 55 (2013), 25–32.
101. Kondo, Y., Nakatani, A., Hayashi, K., Ito, M., Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biol Pharm Bull 23 (2000), 1458–1464.
102. Kumar, S.G., Rahman, M.A., Lee, S.H., Hwang, H.S., Kim, H.A., Yun, J.W., Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9 (2009), 2149–2162.
103. Kunanusornchai, W., Witoonpanich, B., Pichyangkura, R., Chatsudthipong, V., Muanprasat, C., Chitosan oligosaccharide suppresses synovial inflammation via AMPK activation: an in vitro and in vivo study. Pharmacol Res 113 (2016), 458–467.
104. Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53 (2009), 1925–1932.
105. Lee, S.-H., Park, J.-S., Kim, S.-K., Ahn, C.-B., Je, J.-Y., Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Aβ25–35 in PC12 cells. Bioorg Med Chem Lett 19 (2009), 860–862.
106. Lee, S.H., Senevirathne, M., Ahn, C.B., Kim, S.K., Je, J.Y., Factors affecting anti-inflammatory effect of chitooligosaccharides in lipopolysaccharides-induced RAW264.7 macrophage cells. Bioorg Med Chem Lett 19 (2009), 6655–6658.
107. Lee, B.C., Kim, M.S., Choi, S.H., Kim, K.Y., Kim, T.S., In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio Vulnificus. Int J Mol Med 24 (2009), 327–333.
108. Lee, H.-W., Park, Y.-S., Choi, J.-W., Yi, S.-y., Shin, W.-S., Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol Pharm Bull 26 (2003), 1100–1103.
109. Li, C., Fu, R., Yu, C., Li, Z., Guan, H., Hu, D., et al. Silver nanoparticle/chitosan oligosaccharide/poly(vinyl alcohol) nanofibers as wound dressings: a preclinical study. Int J Nanomedicine 8 (2013), 4131–4145.
110. Li, H., Jiang, Z., Han, B., Niu, S., Dong, W., Liu, W., Pharmacokinetics and biodegradation of chitosan in rats. J Ocean Univ China 14 (2015), 897–904.
111. Li, Y., Liu, H., Xu, Q.S., Du, Y.G., Xu, J., Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-kappaB and endothelial inflammatory response. Carbohydr Polym 99 (2014), 568–578.
112. Li, X., Wu, P., Cheng, S., Lv, X., Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of Shiga toxins produced by Escherichia coli. J Med Chem 55 (2012), 2702–2710.
113. Lindsay, R.S., Funahashi, T., Hanson, R.L., Matsuzawa, Y., Tanaka, S., Tataranni, P.A., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002), 57–58.
114. Liu, S.-H., Cai, F.-Y., Chiang, M.-T., Long-term feeding of chitosan ameliorates glucose and lipid metabolism in a high-fructose-diet-impaired rat model of glucose tolerance. Mar Drugs 13 (2015), 7302–7313.
115. Liu, S.-H., Chang, Y.-H., Chiang, M.-T., Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J Agric Food Chem 58 (2010), 5795–5800.
116. Liu, M., Fan, J., Wang, K., He, Z., Synthesis, characterization, and evaluation of phosphated cross-linked konjac glucomannan hydrogels for colon-targeted drug delivery. Drug Deliv 14 (2007), 397–402.
117. Liu, H.T., Huang, P., Ma, P., Liu, Q.S., Yu, C., Du, Y.G., Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases. Acta Pharmacol Sin 32 (2011), 478–486.
118. Liu, H.T., Li, W.M., Li, X.Y., Xu, Q.S., Liu, Q.S., Bai, X.F., et al. Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide-induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases. Basic Clin Pharmacol Toxicol 106 (2010), 362–371.
119. Liu, H.T., Li, W.M., Xu, G., Li, X.Y., Bai, X.F., Wei, P., et al. Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells. Pharmacol Res 59 (2009), 167–175.
120. Liu, B., Liu, W.-S., Han, B.-Q., Sun, Y.-Y., Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World J Gastroenterol 13 (2007), 725–731.
121. Liu, A., Song, W., Cao, D., Liu, X., Jia, Y., Growth inhibition and apoptosis of human leukemia K562 cells induced by seleno-short-chain chitosan. Methods Find Exp Clin Pharmacol 30 (2008), 181–186.
122. Liu, X., Xia, W., Jiang, Q., Xu, Y., Yu, P., Synthesis, characterization, and antimicrobial activity of kojic acid grafted chitosan oligosaccharide. J Agric Food Chem 62 (2014), 297–303.
123. Lodhi, G., Kim, Y.S., Hwang, J.W., Kim, S.K., Jeon, Y.J., Je, J.Y., et al. Chitooligosaccharide and its derivatives: preparation and biological applications. Biomed Res Int, 2014, 2014, 654913.
124. Lu, X., Guo, H., Zhang, Y., Protective effects of sulfated chitooligosaccharides against hydrogen peroxide-induced damage in MIN6 cells. Int J Biol Macromol 50 (2012), 50–58.
125. Lu, Y., Slomberg, D.L., Schoenfisch, M.H., Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. Biomaterials 35 (2014), 1716–1724.
126. Luo, Z., Dong, X., Ke, Q., Duan, Q., Shen, L., Chitooligosaccharides inhibit ethanol-induced oxidative stress via activation of Nrf2 and reduction of MAPK phosphorylation. Oncol Rep 32 (2014), 2215–2222.
127. Luo, Z., Dong, X., Ke, Q., Duan, Q., Shen, L., Downregulation of CD147 by chitooligosaccharide inhibits MMP-2 expression and suppresses the metastatic potential of human gastric cancer. Oncol Lett 8 (2014), 361–366.
128. Luo, Q., Zhao, J., Zhang, X., Pan, W., Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403 (2011), 185–191.
129. Maeda, Y., Kimura, Y., Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr 134 (2004), 945–950.
130. Mao, S., Shuai, X., Unger, F., Simon, M., Bi, D., Kissel, T., The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm 281 (2004), 45–54.
131. Masuda, S., Azuma, K., Kurozumi, S., Kiyose, M., Osaki, T., Tsuka, T., et al. Anti-tumor properties of orally administered glucosamine and N-acetyl-D-glucosamine oligomers in a mouse model. Carbohydr Polym 111 (2014), 783–787.
132. Mattaveewong, T., Wongkrasant, P., Chanchai, S., Pichyangkura, R., Chatsudthipong, V., Muanprasat, C., Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-kappaB and mTOR signaling. Carbohydr Polym 145 (2016), 30–36.
133. Mendis, E., Kim, M.M., Rajapakse, N., Kim, S.K., An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides. Life Sci 80 (2007), 2118–2127.
134. Mhurchu, C.N., Poppitt, S.D., McGill, A.T., Leahy, F.E., Bennett, D.A., Lin, R.B., et al. The effect of the dietary supplement, chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int J Obes Relat Metab Disord 28 (2004), 1149–1156.
135. Michaud, A., Williams, T.A., Chauvet, M.-T., Corvol, P., Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I·. Mol Pharmacol 51 (1997), 1070–1076.
136. Miura, T., Usami, M., Tsuura, Y., Ishida, H., Seino, Y., Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol Pharm Bull 18 (1995), 1623–1625.
137. Molteni, M., Gemma, S., Rossetti, C., The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediat Inflamm, 2016, 2016, 6978936.
138. Moon, J.S., Kim, H.K., Koo, H.C., Joo, Y.S., Nam, H.M., Park, Y.H., et al. The antibacterial and immunostimulative effect of chitosan-oligosaccharides against infection by Staphylococcus aureus isolated from bovine mastitis. Appl Microbiol Biotechnol 75 (2007), 989–998.
139. Muanprasat, C., Wongkrasant, P., Satitsri, S., Moonwiriyakit, A., Pongkorpsakol, P., Mattaveewong, T., et al. Activation of AMPK by chitosan oligosaccharide in intestinal epithelial cells: mechanism of action and potential applications in intestinal disorders. Biochem Pharmacol 96 (2015), 225–236.
140. Murata, M., Nakano, K., Tahara, K., Tozuka, Y., Takeuchi, H., Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers. Eur J Pharm Biopharm 80 (2012), 340–346.
141. Naito, Y., Tago, K., Nagata, T., Furuya, M., Seki, T., Kato, H., et al. A 90-day ad libitum administration toxicity study of oligoglucosamine in F344 rats. Food Chem Toxicol 45 (2007), 1575–1587.
142. Nam, K.S., Shon, Y.H., Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J Microbiol Biotechnol 19 (2009), 629–633.
143. Nam, K.S., Kim, M.K., Shon, Y.H., Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis. J Microbiol Biotechnol 17 (2007), 1546–1549.
144. Nam, K.S., Kim, M.K., Shon, Y.H., Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide. J Microbiol Biotechnol 17 (2007), 2042–2045.
145. Nauss, J.L., Thompson, J.L., Nagyvary, J., The binding of micellar lipids to chitosan. Lipids 18 (1983), 714–719.
146. Ngo, D.-N., Qian, Z.-J., Je, J.-Y., Kim, M.-M., Kim, S.-K., Aminoethyl chitooligosaccharides inhibit the activity of angiotensin converting enzyme. Process Biochem 43 (2008), 119–123.
147. Ngo, D.-H., Qian, Z.-J., Vo, T.-S., Ryu, B., Ngo, D.-N., Kim, S.-K., Antioxidant activity of gallate-chitooligosaccharides in mouse macrophage RAW264.7 cells. Carbohydr Polym 84 (2011), 1282–1288.
148. Onishi, H., Machida, Y., Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20 (1999), 175–182.
149. Pangestuti, R., Bak, S.S., Kim, S.K., Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway. Int J Biol Macromol 49 (2011), 599–606.
150. Park, P.-J., Ahn, C.-B., Jeon, Y.-J., Je, J.-Y., Renin inhibition activity by chitooligosaccharides. Bioorg Med Chem Lett 18 (2008), 2471–2474.
151. Park, J.K., Chung, M.J., Choi, H.N., Park, Y.I., Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity. Int J Mol Sci 12 (2011), 266–277.
152. Park, P.-J., Je, J.-Y., Kim, S.-K., Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. J Agric Food Chem 51 (2003), 4930–4934.
153. Park, P.J., Je, J.Y., Kim, S.K., Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J Agric Food Chem 51 (2003), 4624–4627.
154. Patchett, A.A., Harris, E., Tristram, E.W., Wyvratt, M.J., Wu, M.T., Taub, D., et al. A new class of angiotensin-converting enzyme inhibitors. Nature 288 (1980), 280–283.
155. Patil, R.S., Ghormade, V., Deshpande, M.V., Chitinolytic enzymes: an exploration. Enzym Microb Technol 26 (2000), 473–483.
156. Paul-Clark, M.J., George, P.M., Gatheral, T., Parzych, K., Wright, W.R., Crawford, D., et al. Pharmacology and therapeutic potential of pattern recognition receptors. Pharmacol Ther 135 (2012), 200–215.
157. Pelletier, J.P., Martel-Pelletier, J., Abramson, S.B., Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44 (2001), 1237–1247.
158. Pokhis, K., Bitterlich, N., Cornelli, U., Cassano, G., Efficacy of polyglucosamine for weight loss-confirmed in a randomized double-blind, placebo-controlled clinical investigation. BMC Obes, 2, 2015, 25.
159. Qian, Z.J., Eom, T.K., Ryu, B., Kim, S.K., Angiotensin I-converting enzyme inhibitory activity of sulfated chitooligosaccharides with different molecular weights. J Chitin Chitosan 15 (2010), 75–79.
160. Qiao, Y., Bai, X.F., Du, Y.G., Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress. Int Immunopharmacol 11 (2011), 121–127.
161. Qin, C., Gao, J., Wang, L., Zeng, L., Liu, Y., Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. Food Chem Toxicol 44 (2006), 855–861.
162. Rani, V., Deep, G., Singh, R.K., Palle, K., Yadav, U.C., Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci 148 (2016), 183–193.
163. Rebecca, C., Danik, M., The effects of bioactive compounds on biomarkers of obesity. Funct Foods Health Dis 5 (2015), 365–380.
164. Rong Huei, C., Jaan Rong, C., Ju Shii, S., Effects of ultrasonic conditions and storage in acidic solutions on changes in molecular weight and polydispersity of treated chitosan. Carbohydr Res 299 (1997), 287–294.
165. Sanna, V., Pala, N., Sechi, M., Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine 9 (2014), 467–483.
166. Selkoe, D.J., Hardy, J., The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8 (2016), 595–608.
167. Seo, W.G., Pae, H.O., Kim, N.Y., Oh, G.S., Park, I.S., Kim, Y.H., et al. Synergistic cooperation between water-soluble chitosan oligomers and interferon-gamma for induction of nitric oxide synthesis and tumoricidal activity in murine peritoneal macrophages. Cancer Lett 159 (2000), 189–195.
168. Seyfarth, F., Schliemann, S., Elsner, P., Hipler, U.C., Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata. Int J Pharm 353 (2008), 139–148.
169. Shao, K., Han, B., Dong, W., Song, F., Liu, W., Liu, W., Pharmacokinetics and biodegradation performance of a hydroxypropyl chitosan derivative. J Ocean Univ China 14 (2015), 888–896.
170. Shen, K.T., Chen, M.H., Chan, H.Y., Jeng, J.H., Wang, Y.J., Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food Chem Toxicol 47 (2009), 1864–1871.
171. Shon, Y.H., Nam, K.S., Inhibition of polyamine biosynthesis in Acanthamoeba castellanii and 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by chitosanoligosaccharide. Biotechnol Lett 25 (2003), 701–704.
172. Simunek, J., Brandysova, V., Koppova, I., Simunek, J. Jr., The antimicrobial action of chitosan, low molar mass chitosan, and chitooligosaccharides on human colonic bacteria. Folia Microbiol (Praha) 57 (2012), 341–345.
173. Stelmashook, E.V., Isaev, N.K., Genrikhs, E.E., Amelkina, G.A., Khaspekov, L.G., Skrebitsky, V.G., et al. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases. Biochemistry (Mosc) 79 (2014), 391–396.
174. Sumiyoshi, M., Kimura, Y., Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 58 (2006), 201–207.
175. Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
176. Takimoto, H., Hasegawa, M., Yagi, K., Nakamura, T., Sakaeda, T., Hirai, M., Proapoptotic effect of a dietary supplement: water soluble chitosan activates caspase-8 and modulating death receptor expression. Drug Metab Pharmacokinet 19 (2004), 76–82.
177. Termsarasab, U., Cho, H.J., Kim, D.H., Chong, S., Chung, S.J., Shim, C.K., et al. Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery. Int J Pharm 441 (2013), 373–380.
178. Torzsas, T.L., Kendall, C.W., Sugano, M., Iwamoto, Y., Rao, A.V., The influence of high and low molecular weight chitosan on colonic cell proliferation and aberrant crypt foci development in CF1 mice. Food Chem Toxicol 34 (1996), 73–77.
179. Trivedi, V.R., Satia, M.C., Deschamps, A., Maquet, V., Shah, R.B., Zinzuwadia, P.H., et al. Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction. Nutr J, 15, 2016, 3.
180. Ueno, H., Yamada, H., Tanaka, I., Kaba, N., Matsuura, M., Okumura, M., et al. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 20 (1999), 1407–1414.
181. Vo, T.-S., Kong, C.-S., Kim, S.-K., Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells. Carbohydr Polym 84 (2011), 649–655.
182. Walsh, A.M., Sweeney, T., Bahar, B., O'Doherty, J.V., Multi-functional roles of chitosan as a potential protective agent against obesity. PLoS One, 8, 2013, e53828.
183. Wang, Z., Zheng, L., Yang, S., Niu, R., Chu, E., Lin, X., N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochem Biophys Res Commun 357 (2007), 26–31.
184. Wang, Y., Zhou, P., Yu, J., Pan, X., Wang, P., Lan, W., et al. Antimicrobial effect of chitooligosaccharides produced by chitosanase from Pseudomonas CUY8. Asia Pac J Clin Nutr 16:Suppl 1 (2007), 174–177.
185. Wang, G., Chen, Y., Wang, P., Wang, Y., Hong, H., Li, Y., et al. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Acta Biomater 29 (2016), 248–260.
186. Wang, J.J., Zeng, Z.W., Xiao, R.Z., Xie, T., Zhou, G.L., Zhan, X.R., et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6 (2011), 765–774.
187. Wang, Y., Zhao, Y., Sun, C., Hu, W., Zhao, J., Li, G., et al. Chitosan degradation products promote nerve regeneration by stimulating Schwann cell proliferation via miR-27a/FOXO1 Axis. Mol Neurobiol 53 (2016), 28–39.
188. Wenwei, Z., Xiaoguang, Z., Li, Y., Yuefang, Z., Jiazhen, S., Some chemical changes in chitosan induced by γ-ray irradiation. Polym Degrad Stab 41 (1993), 83–84.
189. Wu, G.J., Tsai, G.J., Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages. Food Chem Toxicol 45 (2007), 250–258.
190. Wydro, P., Krajewska, B., Hac-Wydro, K., Chitosan as a lipid binder: a langmuir monolayer study of chitosan–lipid interactions. Biomacromolecules 8 (2007), 2611–2617.
191. Xiong, C., Wu, H., Wei, P., Pan, M., Tuo, Y., Kusakabe, I., et al. Potent angiogenic inhibition effects of deacetylated chitohexaose separated from chitooligosaccharides and its mechanism of action in vitro. Carbohydr Res 344 (2009), 1975–1983.
192. Xu, W., Huang, H.C., Lin, C.J., Jiang, Z.F., Chitooligosaccharides protect rat cortical neurons against copper induced damage by attenuating intracellular level of reactive oxygen species. Bioorg Med Chem Lett 20 (2010), 3084–3088.
193. Xu, Q., Ma, P., Yu, W., Tan, C., Liu, H., Xiong, C., et al. Chitooligosaccharides protect human embryonic hepatocytes against oxidative stress induced by hydrogen peroxide. Mar Biotechnol (NY) 12 (2010), 292–298.
194. Xu, Y., Wang, L., Li, Y.K., Wang, C.Q., Oxidation and pH responsive nanoparticles based on ferrocene-modified chitosan oligosaccharide for 5-fluorouracil delivery. Carbohydr Polym 114 (2014), 27–35.
195. Yeh, M.Y., Wu, M.F., Shang, H.S., Chang, J.B., Shih, Y.L., Chen, Y.L., et al. Effects of chitosan on xenograft models of melanoma in C57BL/6 mice and hepatoma formation in SCID mice. Anticancer Res 33 (2013), 4867–4873.
196. Yoon, H.J., Moon, M.E., Park, H.S., Im, S.Y., Kim, Y.H., Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 358 (2007), 954–959.
197. Yoon, N.Y., Ngo, D.-N., Kim, S.-K., Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives. Carbohydr Polym 78 (2009), 869–872.
198. Yoon, H.J., Park, H.S., Bom, H.S., Roh, Y.B., Kim, J.S., Kim, Y.H., Chitosan oligosaccharide inhibits 203HgCl2-induced genotoxicity in mice: micronuclei occurrence and chromosomal aberration. Arch Pharm Res 28 (2005), 1079–1085.
199. You, Y., Park, W.H., Ko, B.M., Min, B.M., Effects of PVA sponge containing chitooligosaccharide in the early stage of wound healing. J Mater Sci Mater Med 15 (2004), 297–301.
200. Yousef, M., Pichyangkura, R., Soodvilai, S., Chatsudthipong, V., Muanprasat, C., Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Pharmacol Res 66 (2012), 66–79.
201. Zaidi, M.R., Merlino, G., The two faces of interferon-gamma in cancer. Clin Cancer Res 17 (2011), 6118–6124.
202. Zeng, L., Qin, C., Wang, W., Chi, W., Li, W., Absorption and distribution of chitosan in mice after oral administration. Carbohydr Polym 71 (2008), 435–440.
203. Zhang, Y., Lee, E.T., Devereux, R.B., Yeh, J., Best, L.G., Fabsitz, R.R., et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the strong heart study. Hypertension 47 (2006), 410–414.
204. Zhang, P., Liu, W., Peng, Y., Han, B., Yang, Y., Toll like receptor 4 (TLR4) mediates the stimulating activities of chitosan oligosaccharide on macrophages. Int Immunopharmacol 23 (2014), 254–261.
205. Zhu, X.L., Du, Y.Z., Yu, R.S., Liu, P., Shi, D., Chen, Y., et al. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate. Int J Mol Sci 14 (2013), 15755–15766.